Positions

Ben F. Love Chair in Cancer Research and Professor
Molecular and Human Genetics
Baylor College of Medicine
Houston, TX, US
Professor
Molecular Virology & Microbiology
Baylor College of Medicine
Leader
Cancer Evolvability Program
Dan L. Duncan Cancer Center
Professor
Biochemistry & Molecular Biology
Baylor College of Medicine

Education

BA from State University of New York
PhD from University of Oregon
Post-Doctoral Fellowship at University of Paris VII
Post-Doctoral Fellowship at University of Utah School of Medicine
Post-Doctoral Fellowship at National Cancer Institute

Honors & Awards

Fellow, American Association for the Advancement of Science (elected)
NIH Director’s Pioneer Award
Fellow, American Academy of Microbiology (elected)
Biosphere and Humanity Medal, Russian Academies of Medicine and Science, 2010
The Michael E. DeBakey Award for Excellence in Research: 2014 & 2001
The Genetics Society of Canada Young Scientist Award
The Eli Lilly National Cancer Institute of Canada William Rawls Prize
Baylor College of Medicine Student Awards for Graduate Teaching Excellence: 2008, 2006, 2001 & 2000

Professional Interests

  • Molecular mechanisms of genome instability in evolution, antibiotic resistance, and cancer

Professional Statement

Genome Instability in Evolution, Antibiotic Resistance, and Cancer

STRESS-INDUCED MUTAGENESIS: For 50 years the world believed that mutations occur at random. The discovery of stress-induced mutagenesis has changed ideas about mutation and evolution and revealed mutagenic programs that differ from standard spontaneous mutagenesis in rapidly proliferating cells. The stress-induced mutations occur during growth-limiting stress, and can include adaptive mutations that allow growth in the otherwise growth-limiting environment. We are elucidating molecular mechanisms by which these mutations form in E. coli using a variety of genetic, molecular, genomic, and whole-genome-sequencing approaches. We discovered that the normally high-fidelity mechanism of DNA double-strand-break repair is switched to a mutagenic version of that mechanism, using a special error-prone DNA polymerase, specifically when cells are stressed, under the control of two cellular stress responses. The stress responses increase mutagenesis specifically when cells are maladapted to their environments, i.e. are stressed, potentially accelerating evolution then. Stress-induced mutation mechanisms may provide important models for genome instability underlying some cancers and genetic diseases, resistance to chemotherapeutic and antibiotic drugs, pathogenicity of microbes, and many other important evolutionary processes. We are interested in molecular mechanisms that drive evolution.

ANTIBIOTIC-RESISTANCE MUTATION: Some mutations that confer antibiotic-resistance form by a mechanism with similarities to recombination-dependent stress-induced mutagenesis described above. We are examining the mechanism by which these mutations form.

Spontaneous DNA Damage: We created E. coli cells that fluoresce green when their DNA is damaged, and are using flow cytometry to quantify and recover green cells with spontaneous DNA damage. With this direct, sensitive technology we are identifying the amounts, kinds, and sources of spontaneous DNA damage in single living cells. Spontaneous DNA damage is thought to be the main culprit underlying genetic and genomic instability in all living cells. We discovered that spontaneous DNA double-strand breaks are rarer and more dangerous to genomes than predicted, and that bacteria with DNA damage undergo a senescence-like state, analogous to that in human cells.

From Bacteria to Humans: Genomic-Caretaker Proteins and Cancer. Genomic instability including mutagenesis and chromosome rearrangement is a hallmark of cancer, yet the genomic caretaker proteins that prevent and sometimes cause instability are highly conserved and similar in all organisms. E. coli RecQ is a close relative of five human proteins, mutations in at least three of which cause genome instability underlying cancer-predisposition syndromes: Bloom, Werner, and Rothmund-Thomson. One of the human, the yeast and fly RecQ homologues, appear to play one specific role in genetic recombination in cells. Surprisingly, we found that E. coli RecQ plays the opposite role, and thus exemplifies a second paradigm for the in vivo function of RecQ-family proteins. We are investigating whether any of the human homologues function via the E. coli RecQ paradigm, and the molecular basis of RecQ action in vivo as a model for human oncogenesis. We are pursuing other promising bacterial homologues of human cancer proteins to learn their mechanisms of action first in the simpler, more tractable bacterial system to provide mechanisms and models for the molecular bases of cancer.

Selected Publications